"RNAi Therapeutics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of disease treatment which involves the silencing of genes that are associated with a disease by the process of RNA INTERFERENCE.
| Descriptor ID |
D000067492
|
| MeSH Number(s) |
E02.095.301.250
|
| Concept/Terms |
RNAi Therapeutics- RNAi Therapeutics
- RNAi-Based Therapeutics
- RNAi-Based Therapy
- RNAi Based Therapy
- RNAi-Based Therapies
- Therapies, RNAi-Based
- Therapy, RNAi-Based
- RNAi Therapy
- RNAi Therapies
- Therapies, RNAi
- Therapy, RNAi
|
Below are MeSH descriptors whose meaning is more general than "RNAi Therapeutics".
Below are MeSH descriptors whose meaning is more specific than "RNAi Therapeutics".
This graph shows the total number of publications written about "RNAi Therapeutics" by people in this website by year, and whether "RNAi Therapeutics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "RNAi Therapeutics" by people in Profiles.
-
Judge DP, Kristen AV, Grogan M, Maurer MS, Falk RH, Hanna M, Gillmore J, Garg P, Vaishnaw AK, Harrop J, Powell C, Karsten V, Zhang X, Sweetser MT, Vest J, Hawkins PN. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovasc Drugs Ther. 2020 06; 34(3):357-370.
-
He S, Cen B, Liao L, Wang Z, Qin Y, Wu Z, Liao W, Zhang Z, Ji A. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo. Drug Deliv. 2017 Nov; 24(1):471-481.
-
Tangudu NK, Verma VK, Clemons TD, Beevi SS, Hay T, Mahidhara G, Raja M, Nair RA, Alexander LE, Patel AB, Jose J, Smith NM, Zdyrko B, Bourdoncle A, Luzinov I, Iyer KS, Clarke AR, Dinesh Kumar L. RNA Interference Using c-Myc-Conjugated Nanoparticles Suppresses Breast and Colorectal Cancer Models. Mol Cancer Ther. 2015 May; 14(5):1259-69.